Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation

NCT01350882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Humoral Rejection in Kidney Transplantation

Interventions

DRUG: MabThera
DRUG: Physiological serum : sodium chloride, sodium citrate

Sponsor

University Hospital, Tours

Collaborators

[object Object]